C

Covetrus Inc
F:2NJ

Watchlist Manager
Covetrus Inc
F:2NJ
Watchlist
Price: 21.52 EUR 0.19% Market Closed
Market Cap: €3B

EV/FCFF

-1.8
Current
20%
Cheaper
vs 3-y average of -2.2

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
-1.8
=
Enterprise Value
€-6.2B
/
Free Cash Flow to Firm
$4B

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
-1.8
=
Enterprise Value
€-6.2B
/
Free Cash Flow to Firm
$4B

Valuation Scenarios

Covetrus Inc is trading above its industry average

If EV/FCFF returns to its Industry Average (23), the stock would be worth €-277.97 (1 392% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-1 402%
Maximum Upside
No Upside Scenarios
Average Downside
1 397%
Scenario EV/FCFF Value Implied Price Upside/Downside
Current Multiple -1.8 €21.52
0%
Industry Average 23 €-277.97
-1 392%
Country Average 23.2 €-280.25
-1 402%

Forward EV/FCFF
Today’s price vs future free cash flow to firm

Not enough data available to calculate forward EV/FCFF

Peer Comparison

All Multiples
EV/FCFF
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 8 393 companies
0th percentile
-1.8
Low
0 — 15.4
Typical Range
15.4 — 35.1
High
35.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 15.4
Median 23.2
70th Percentile 35.1
Max 3 178 983.5

Covetrus Inc
Glance View

Market Cap
3B EUR
Industry
Health Care

Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.

2NJ Intrinsic Value
Not Available
C
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett